Dr. Mohamed Mazen Batterjee is a distinguished pharmaceutical industry leader, entrepreneur, and innovator who serves as Managing Director of Batterjee Pharma—a rapidly growing Saudi-based pharmaceutical manufacturer and contract development and manufacturing organization (CDMO) with a strong regional presence and expanding export footprint across the Middle East and beyond. Under his leadership since 2014, Batterjee Pharma has seen significant growth in both proprietary and contract manufacturing operations, strengthening the company’s capacity to deliver high-quality generics and licensed products while forging strategic partnerships with multinational firms—contributing to its expanding portfolio and rising revenues.

Dr. Batterjee’s academic journey includes a master’s degree from the University of Strathclyde, UK, and a doctorate (DBA) from IE University, Spain, reflecting a blend of global academic exposure and strategic business insight that informs his leadership approach. Prior to his current role, he gained professional experience in diverse corporate and investment leadership roles, including strategic and board positions across sectors—insights he brings to drive innovation and operational excellence at Batterjee Pharma.

In 2021, he expanded his impact in healthcare innovation by co-founding Aumet, a digital health-tech platform that aims to digitize the pharmaceutical procurement cycle, improve supply-chain efficiency, and enhance medication availability for pharmacies and healthcare providers—a vision driven by his belief in making healthcare more accessible through technology.

Dr. Batterjee’s leadership has earned recognition in industry circles, including inclusion in Forbes Middle East’s Top Healthcare Leaders lists—testimony to his influence in shaping the pharma and health-tech landscape in the region.

Called upon for his strategic mindset, operational rigor, and commitment to healthcare innovation, Dr. Mohamed Mazen Batterjee continues to guide Batterjee Pharma and Aumet toward expanded impact, aligning business growth with broader goals of quality, access, and sustainable healthcare advancement.